Up to 95 per cent of patients receiving radiation therapy for cancer experience acute radiation dermatitis (ARD), which is characterised by red, painful, itchy, or peeling skin. Although little is known about why this condition develops and no standardised treatments for preventing severe AR
A method that malignant tumours use to remotely prevent the emergence of an immune response that would halt their growth has been discovered by researchers at Baylor College of Medicine and associated institutions.
AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has received approval from the Drug Controller General of India (DCGI) for the cancer drug Trastuzumab Deruxtecan for the treatment of metastatic breast cancer.
Female healthcare workers who are regularly exposed to radiation from x-rays and other imaging procedures require stronger ionising radiation protection to help reduce their risk of developing breast cancer, according to physicians writing in The BMJ.
The latest study suggested that patients who have multiple tumours in one breast may be able to avoid a mastectomy if the tumours can be removed while leaving enough breast tissue.
Women in healthcare who are often exposed to radiation from X-rays and other imaging procedures require stronger ionising radiation protection to help reduce their risk of developing breast cancer, according to physicians writing in The BMJ.
Higher Body Mass Index is a risk factor for delayed wound healing in patients undergoing breast reduction surgery (reduction mammaplasty), according to a study published in the Plastic and Reconstructive Surgery® the official medical journal of the American Society of Plastic Surgeons (
According to a study, ultrasound works well as a stand-alone diagnostic technique for patients with specific breast symptoms. Focal breast complaints can relate to symptoms and conditions that are limited to a particular location of the breast, such as pain, tumours, nipple discharge, or oth
Options for treatment are limited when cancer spreads to the brain. The majority of medications made to fight metastases either cannot penetrate the blood-brain barrier or are ineffective against brain metastases.